Table II.
Operative characteristics
| Variable | % (No.) (N = 192) |
|---|---|
|
| |
| Procedure status | |
| Elective | 75.0 (144) |
| Urgent or emergent | 25.0 (48) |
| Indication for TEVAR | |
| DTA, fusiform | 55.2 (106) |
| DTA, saccular | 41.7 (80) |
| DTA, fusiform and saccular | 3.1 (6) |
| Access vessel | |
| Femoral | 82.8 (159) |
| Iliac | 17.2 (33) |
| Infrarenal aorta | 0.5 (1) |
| Other | 1.0 (2) |
| Left subclavian artery coverage | 45.8 (88) |
| Maximum aortic diameter, cm | 5.9 ± 1.5 |
| Type of endograft | |
| Gore TAG/C-TAGa | 57.8 (111) |
| Medtronic Talent/Valiantb | 24.0 (46) |
| Cook Zenith TX2/Alpha Thoracicc | 16.1 (31) |
| Bolton Relayd | 1.6 (3) |
| Medtronic Aneurxb | 0.5 (1) |
| Endografts used, median | 2 (1–5) |
| Intraoperative CSF drainage | 12.5 (24) |
CSF, Cerebrospinal fluid; DTA, descending thoracic aneurysm; TEVAR, thoracic endovascular aortic repair.
a
W. L. Gore and Associates, Flagstaff, Ariz.
b
Medtronic, Minneapolis, Minn.
c
Cook, Bloomington, Ind.
d
Bolton Medical, Inc, Sunrise, Fla.